Yes that is an important distinction. Whilst we released two sets of positive data in that time Acadia announced a failed trial with Nuplazid and paused all plans to further expand the drug into other indications.
- Forums
- ASX - By Stock
- Acadia
Yes that is an important distinction. Whilst we released two...
-
- There are more pages in this discussion • 182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.38 |
Change
-0.825(5.81%) |
Mkt cap ! $1.710B |
Open | High | Low | Value | Volume |
$13.88 | $13.91 | $13.29 | $7.319M | 541.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 679 | $13.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.39 | 1094 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 754 | 13.370 |
6 | 803 | 13.360 |
11 | 1638 | 13.350 |
13 | 4575 | 13.340 |
5 | 3162 | 13.330 |
Price($) | Vol. | No. |
---|---|---|
13.390 | 1137 | 18 |
13.400 | 739 | 6 |
13.410 | 643 | 6 |
13.420 | 814 | 4 |
13.430 | 827 | 4 |
Last trade - 13.47pm 08/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |